Cooper Creek Partners Management’s Medifast MED Stock Holding History

Cooper Creek Partners Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-149,863	Closed	-$25.6M	–	127
2022 Q1	$25.6M	Buy	149,863 +56,547	+61%	+$10.7M	2.64%	9
2021 Q4	$19.5M	Buy	93,316 +36,942	+66%	+$7.64M	2.26%	11
2021 Q3	$10.9M	Buy	+56,374	New	+$13.9M	1.47%	24
2015 Q3	–	Sell	-64,580	Closed	-$2.09M	–	32
2015 Q2	$2.09M	Sell	64,580 -54,900	-46%	-$1.74M	2.26%	19
2015 Q1	$3.58M	Buy	119,480 +2,514	+2%	+$79.8K	3.41%	12
2014 Q4	$3.92M	Buy	116,966 +10,373	+10%	+$323K	4.13%	8
2014 Q3	$3.5M	Buy	+106,593	New	+$3.27M	3.85%	7

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Cooper Creek Partners Management's MED Position: Q2 2022 in Review

Cooper Creek Partners Management sold out of Medifast (MED) in Q2 2022, closing a stake of 149,863 shares — an estimated $25.6M sold.

Cooper Creek Partners Management first reported a position in MED in Q3 2014 and held it in 7 quarters. The position peaked at $25.6M in Q1 2022. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Cooper Creek Partners Management reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
Cooper Creek Partners Management sold 149,863 Medifast shares in Q2 2022, an estimated $25.6M.
Cooper Creek Partners Management first reported a position in Medifast in Q3 2014 and held it in 7 quarters.
Cooper Creek Partners Management's Medifast position peaked at $25.6M in Q1 2022.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Cooper Creek Partners Management's 13F filing for Q2 2022, filed 15 Aug 2022.